Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleChemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
- Where
- Baltimore
- Age
- 21 years and over
- People
- 15
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT06546969 - Phase 2Taking peopleDurvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
- Where
- San Francisco
- Age
- 18 years and over
- People
- 21
- Run by
- Mary Feng, MD
See details and how to joinNCT04430452 - Phase 1Taking peopleDNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
- Where
- Baltimore
- Age
- 12 years and over
- People
- 56
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT04248569 - Phase 2Taking peoplePerioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
- Where
- Baltimore
- Age
- 18 years and over
- People
- 27
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06001658 - Phase 1Not yet taking people in United StatesCytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
- Where
- Seattle
- Age
- 21 years and over
- People
- 21
- Run by
- Seattle Children's Hospital
See details and how to joinNCT07224568 - Phase 1Taking peopleImmunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
- Where
- Houston
- Age
- Up to 21 years
- People
- 21
- Run by
- Baylor College of Medicine
See details and how to joinNCT06198296 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - No phaseTaking peopleTissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
- Where
- Chicago
- People
- 1,000
- Run by
- University of Chicago
See details and how to joinNCT01416714 - No phaseTaking peopleOptimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
- Where
- Pittsburgh
- Age
- 18 years to 89 years
- People
- 48
- Run by
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
See details and how to joinNCT06731998 - Phase 2Taking peopleEGCG for Hepatocellular Carcinoma Chemoprevention
- Where
- Dallas
- Age
- 18 years and over
- People
- 60
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06015022 - No phaseTaking people90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia
- Where
- New Orleans
- Age
- 18 years and over
- People
- 50
- Run by
- Ochsner Health System
See details and how to joinNCT05953961 - Phase 1/2Taking peopleA Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
- Where
- Charlotte, Chicago, Dallas, Duarte, Houston, Miami, Seattle
- Age
- 18 years and over
- People
- 178 worldwide
- Run by
- Iterion Therapeutics
See details and how to joinNCT05797805 - No phaseEnrolling by invitationClinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy
- Where
- New York, Washington D.C.
- Age
- 18 years and over
- People
- 104
- Run by
- MediView XR, Inc.
See details and how to joinNCT07046832 - No phaseNot yet taking people in United StatesLTFU for All Cell and Gene Therapy Studies
- Where
- Atlanta, Columbus, Duarte, Hackensack, Houston, Jacksonville, New York, Orange, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Francisco, St Louis, Tampa, Washington D.C., Westwood
- Age
- 18 years to 130 years
- People
- 64 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06194461 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Chicago, New Haven
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseNot yet taking people in United StatesSeravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis
- Where
- Boston
- Age
- 21 years to 84 years
- People
- 1,392
- Run by
- ImCare Biotech
See details and how to joinNCT06994130 - Phase 1Taking peopleIntra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
- Where
- Pittsburgh
- Age
- 18 years to 69 years
- People
- 18
- Run by
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
See details and how to joinNCT07001592 - No phaseNot yet taking people in United StatesThe Dragon PLC Trial (DRAGON-PLC)
- Where
- Chicago, Cleveland, New Haven, New York, Rochester
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- Maastricht University
See details and how to joinNCT06914648 - Phase 3Not yet taking people in United StatesNamodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- Where
- Dallas
- Age
- 18 years and over
- People
- 471 worldwide
- Run by
- Can-Fite BioPharma
See details and how to joinNCT05201404 - Phase 1/2Active, not recruitingStudy of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors
- Where
- San Antonio, Spokane, Tyler
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- TiumBio Co., Ltd.
See details and how to joinNCT05784688 - No phaseTaking peopleA Multicenter Cancer Biospecimen Collection Study
- Where
- San Francisco
- Age
- 18 years and over
- People
- 1,650
- Run by
- Cofactor Genomics, Inc.
See details and how to joinNCT04510129 - Phase 1/2Taking peopleA Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
- Where
- New York
- Age
- 18 years to 70 years
- People
- 46 worldwide
- Run by
- SCG Cell Therapy Pte. Ltd.
See details and how to joinNCT05417932 - No phaseNot yet taking people in United StatesCell-Surface Plectin in the Diagnosis of Cholangiocarcinoma from ERCP-directed Biliary Samples
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 100
- Run by
- University of Virginia
See details and how to joinNCT06651346 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Where
- Cleveland, Jacksonville, New York, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- GI Innovation, Inc.
See details and how to joinNCT05824975 - No phaseTaking peopleThe DRAGON 2 Trial
- Where
- New Haven
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Maastricht University
See details and how to joinNCT05428735